Stephen Obaro | Professor of Pediatrics and Infectious Diseases
University of Alabama at Birmingham

Stephen Obaro, Professor of Pediatrics and Infectious Diseases, University of Alabama at Birmingham

Stephen Obaro MBBS, FWACP, MRCP(UK), FRCPCH, FAAP, PhD is Professor of Pediatrics and Infectious Diseases, Helen and Robert Whitley Endowed Chair of Pediatric Infectious Diseases, Associate Director, Mary Heersink Institute of Global Health, University of Alabama at Birmingham, AL. USA.  He is a trustee and co-founder of International Foundation Against Infectious Diseases in Nigeria (IFAIN), a non-governmental, not-for- profit organization that has established a platform for multidisciplinary research. The IFAIN Laboratory network offers a training and research platform for basic and clinical microbiologists in Nigeria through partner institutions in-country and collaborators in the US and UK. In collaboration with the African Center for Genomics and Infectious Diseases, he is currently supporting surveillance for antimicrobial resistance surveillance in Nigeria and Rwanda through funding support from the National Institute of Health.

Appearances:



Day 2 - World Antimicrobial Resistance Congress & Disease Prevention Control Summit 2024 @ 11:40

Panel: Diagnostics partnerships to combat AMR in LMICs

This panel will feature a discussion on partnerships that are focused on advancing diagnostics in LMICs to guide use of appropriate antibiotics. Panelists will share updates on their programs from different perspectives such as a donor perspective, an implementor experience and from a product development partnership perspective. Learn about the newly launched partnership  called AMRASI (Antimicrobial Access and Stewardship Initiative) from Elijah Kahn from USAID, an update from on the Nigeria field studies to understand the epidemiology of bacteremia syndromes in children from Dr. Obaro from the University of Alabama, Bringham and about new diagnostics products and programs from Kavi Ramjeet of FIND. The panel will be moderated by David Ripin, Chief Science Officer | Clinton Health Access Initiative.

last published: 14/Nov/24 16:45 GMT
last published: 14/Nov/24 16:45 GMT

back to speakers